NOS3 polymorphisms are associated with arterial stiffness in children with type 1 diabetesZINEH, Issam; BEITELSHEES, Amber L; HALLER, Michael J et al.Diabetes care. 2007, Vol 30, Num 3, pp 689-693, issn 0149-5992, 5 p.Article

Serum Monocyte Chemoattractant Protein-1 Concentrations Associate With Diabetes Status but Not Arterial Stiffness in Children With Type 1 DiabetesZINEH, Issam; BEITELSHEES, Amber L; SILVERSTEIN, Janet H et al.Diabetes care. 2009, Vol 32, Num 3, pp 465-467, issn 0149-5992, 3 p.Article

Discordant β-blocker effects on clinic, ambulatory, resting, and exercise hemodynamics in patients with hypertensionBEITELSHEES, Amber L; ZINEH, Issam; YARANDI, Hossein N et al.Pharmacotherapy. 2006, Vol 26, Num 9, pp 1247-1254, issn 0277-0008, 8 p.Article

Cost-Effectiveness of Cytochrome P450 2C19 Genotype Screening for Selection of Antiplatelet Therapy with Clopidogrel or PrasugrelREESE, Emily S; MULLINS, C. Daniel; BEITELSHEES, Amber L et al.Pharmacotherapy. 2012, Vol 32, Num 4, pp 323-332, issn 0277-0008, 10 p.Article

Single nucleotide polymorphism discovery and haplotype analysis of Ca²⁺ -dependent K⁺ channel beta-1 subunitYAN GONG; BEITELSHEES, Amber L; WESSEL, Jennifer et al.Pharmacogenetics and genomics (Print). 2007, Vol 17, Num 4, pp 267-275, issn 1744-6872, 9 p.Article

Discordance between availability of pharmacogenetics studies and pharmacogenetics-based prescribing information for the top 200 drugsZINEH, Issam; PEBANCO, Glenn D; AQUILANTE, Christina L et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 4, pp 639-644, issn 1060-0280, 6 p.Article

Predictors for Glucose Change in Hypertensive Participants Following Short-term Treatment with Atenolol or HydrochlorothiazideMOORE, Mariellen J; YAN GONG; BAILEY, Kent et al.Pharmacotherapy. 2014, Vol 34, Num 11, pp 1132-1140, issn 0277-0008, 9 p.Article

Impact of Abdominal Obesity on Incidence of Adverse Metabolic Effects Associated With Antihypertensive MedicationsCOOPER-DEHOFF, Rhonda M; SHERON WEN; BOERWINKLE, Eric et al.Hypertension (Dallas, Tex. 1979). 2010, Vol 55, Num 1, pp 61-68, issn 0194-911X, 8 p.Article

Adrenergic-Pathway Gene Variants Influence Beta-Blocker―Related Outcomes After Acute Coronary Syndrome in a Race-Specific MannerCRESCI, Sharon; DORN, Gerald W; JONES, Philip G et al.Journal of the American College of Cardiology. 2012, Vol 60, Num 10, pp 898-907, issn 0735-1097, 10 p.Article

Hypertension Susceptibility Loci and Blood Pressure Response to Antihypertensives: Results From the Pharmacogenomic Evaluation of Antihypertensive Responses StudyYAN GONG; MCDONOUGH, Caitrin W; BOERWINKLE, Eric et al.Circulation. Cardiovascular genetics (Print). 2012, Vol 5, Num 6, pp 686-691, issn 1942-325X, 6 p.Article

G Protein Receptor Kinase 4 Polymorphisms β-Blocker Pharmacogenetics and Treatment-Related Outcomes in HypertensionVANDELL, Alexander G; LOBMEYER, Maximilian T; BAILEY, Kent R et al.Hypertension (Dallas, Tex. 1979). 2012, Vol 60, Num 4, pp 957-964, issn 0194-911X, 8 p.Article

PROX1 Gene Variant is Associated with Fasting Glucose Change After Antihypertensive Treatment : INDIVIDUALIZED PHARMACOTHERAPYYAN GONG; MCDONOUGH, Caitrin W; JOHNSON, Julie A et al.Pharmacotherapy. 2014, Vol 34, Num 2, pp 123-130, issn 0277-0008, 8 p.Article

Large-Scale Gene-Centric Meta-analysis across 32 Studies Identifies Multiple Lipid LociASSELBERGS, Folkert W; YIRAN GUO; BAUMERT, Jens et al.American journal of human genetics. 2012, Vol 91, Num 5, pp 823-838, issn 0002-9297, 16 p.Article

Chromosome 9p21 Haplotypes and Prognosis in White and Black Patients With Coronary Artery DiseaseYAN GONG; BEITELSHEES, Amber L; JOHNSON, Julie A et al.Circulation. Cardiovascular genetics (Print). 2011, Vol 4, Num 2, pp 169-178, issn 1942-325X, 10 p.Article

Plasma Renin Activity Predicts Blood Pressure Responses to β-Blocker and Thiazide Diuretic as Monotherapy and Add-On Therapy for HypertensionTURNER, Stephen T; SCHWARTZ, Gary L; CHAPMAN, Arlene B et al.American journal of hypertension. 2010, Vol 23, Num 9, pp 1014-1022, issn 0895-7061, 9 p.Article

Synergistic polymorphisms of β1 and α_2C-adrenergic receptors and the influence on left ventricular ejection fraction response to β-blocker therapy in heart failureLOBMEYER, Maximilian T; YAN GONG; HILL, James A et al.Pharmacogenetics and genomics (Print). 2007, Vol 17, Num 4, pp 277-282, issn 1744-6872, 6 p.Article

Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertensionZINEH, Issam; BEITELSHEES, Amber L; GAEDIGK, Andrea et al.Clinical pharmacology and therapeutics. 2004, Vol 76, Num 6, pp 536-544, issn 0009-9236, 9 p.Article

Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patientsLOBMEYER, Maximilian T; LIEWEI WANG; PEPINE, Carl J et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 1, pp 42-49, issn 1744-6872, 8 p.Article

Pharmacogenomics of antihypertensive drugs : Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) studyJOHNSON, Julie A; BOERWINKLE, Eric; SCHWARTZ, Gary et al.The American heart journal. 2009, Vol 157, Num 3, pp 442-449, issn 0002-8703, 8 p.Article

Α-Adducin polymorphism associated with increased risk of adverse cardiovascular outcomes : Results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES)GERHARD, Tobias; YAN GONG; JOHNSON, Julie A et al.The American heart journal. 2008, Vol 156, Num 2, pp 397-404, issn 0002-8703, 8 p.Article

Genomic Association Analysis of Common Variants Influencing Antihypertensive Response to HydrochlorothiazideTURNER, Stephen T; BOERWINKLE, Eric; PADMANABHAN, Sandosh et al.Hypertension (Dallas, Tex. 1979). 2013, Vol 62, Num 2, pp 391-397, issn 0194-911X, 7 p.Article

Blood Pressure Responses and Metabolic Effects of Hydrochlorothiazide and AtenololSMITH, Steven M; YAN GONG; TURNER, Stephen T et al.American journal of hypertension. 2012, Vol 25, Num 3, pp 359-365, issn 0895-7061, 7 p.Article

Interaction between the UCP2 -866 G>A polymorphism, diabetes, and β-blocker use among patients with acute coronary syndromesBEITELSHEES, Amber L; FINCK, Brian N; SPERTUS, John A et al.Pharmacogenetics and genomics (Print). 2010, Vol 20, Num 4, pp 231-238, issn 1744-6872, 8 p.Article

Genetic Variation in the β2 Subunit of the Voltage-Gated Calcium Channel and Pharmacogenetic Association With Adverse Cardiovascular Outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES)YUXIN NIU; YAN GONG; LANGAEE, Taimour Y et al.Circulation. Cardiovascular genetics (Print). 2010, Vol 3, Num 6, pp 548-555, issn 1942-325X, 8 p.Article

KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST)BEITELSHEES, Amber L; YAN GONG; JOHNSON, Julie A et al.Pharmacogenetics and genomics (Print). 2007, Vol 17, Num 9, pp 719-729, issn 1744-6872, 11 p.Article